Keyphrases
Lung Cancer
100%
Mechanistic Modeling
100%
Combination of Therapies
100%
MicroRNA-155 (miR-155)
100%
Anti-microRNA
100%
Non-small Cell Lung Cancer (NSCLC)
75%
Drug Synergy
75%
Standard of Care
50%
Mathematical Model
25%
Treatment Strategy
25%
Clinical Significance
25%
Tumor Response
25%
Tumor Growth
25%
Cancer Tumor
25%
Effective Dose
25%
Treatment Outcome
25%
Treatment Efficacy
25%
Drug Target
25%
In Vivo Pharmacokinetics
25%
Nanotherapeutics
25%
Drug Exposure
25%
Lung Cancer Treatment
25%
Pharmacodynamics
25%
Cancer Outcomes
25%
Novel Nanoparticles
25%
Programmed Death-ligand 1 (PD-L1)
25%
Atezolizumab
25%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Combination Therapy
100%
microRNA 155
100%
Non Small Cell Lung Cancer
75%
Synergism
75%
Pharmacokinetic
25%
Pharmacodynamics
25%
Nanoparticle
25%
Neoplasm
25%
Tumor Growth
25%
Immunotherapy
25%
Drug Delivery System
25%
Atezolizumab
25%